Healthcare -
Biotechnology - NASDAQ - US
$ 0.6932
-6.3 %
$ 35.9 M
Market Cap
-0.64
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Xilio Therapeutics, Inc.
| Revenue | 6.34 M |
| Cost Of Revenue | 1.64 M |
| Gross Profit | 4.7 M |
| Operating Expenses | 66.9 M |
| Operating Income | -60.6 M |
| Other Expenses | -2.34 M |
| Net Income | -58.2 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 6.3 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 1.6 | 1.9 | 1.8 | 1.5 | 1.1 | 0.2 |
| Gross Profit | 4.7 | (1.9) | (1.8) | (1.5) | (1.1) | (0.2) |
| OPERATING INCOME | ||||||
| Operating Expenses | 66.9 | 79.1 | 89.1 | 75.0 | 54.6 | 19.0 |
| Selling, General and Administrative Expenses | 24.8 | 27.0 | 29.9 | 23.9 | 10.7 | 4.8 |
| Research and Development Expenses | 41.2 | 52.1 | 59.2 | 51.2 | 43.9 | 14.3 |
| Operating Income | (60.6) | (79.1) | (89.1) | (75.0) | (54.6) | (19.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 0 | 0.6 | 0.6 | 0 |
| Total Other Income | 2.3 | 2.7 | 0.9 | (0.8) | (0.7) | 1.7 |
| Pre-Tax Income | (58.2) | (76.4) | (88.2) | (75.8) | (55.2) | (17.3) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (0.9) | (1.5) | 0.9 | 68.1 K |
| Net Income | (58.2) | (76.4) | (87.3) | (74.3) | (55.2) | (17.3) |
| EPS | 1.09 | 2.78 | 3.19 | 2.72 | 2.01 | 0.0006 |